
Valsartan
Valsartan lowers blood pressure about as much as other ARBs and ACE inhibitors, cut hospital stays for heart failure in a large trial without changing survival, and was as effective as captopril after a heart attack with a weakened heart. Adding it to an ACE inhibitor brought more side effects without better survival. Its most important risks are harm to a developing baby (boxed warning), high blood potassium and reduced kidney function in vulnerable people. For supplements and foods, potassium supplements and potassium salt substitutes are the main concern; celery and spirulina may add a little to its blood pressure lowering.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with high blood pressure, heart failure, or a weakened heart after a heart attack, and children 1 year and older with high blood pressure, treated and monitored by a prescriber
Common dosing range
Set by your prescriber. For adult high blood pressure, Diovan starts at 80 or 160 mg once daily (range 80 to 320 mg), while Prexxartan oral solution has its own twice-daily dosing; for heart failure, 40 mg twice daily, raised to 160 mg twice daily as tolerated; after a heart attack, 20 mg twice daily, raised toward 160 mg twice daily
When to expect effects
Blood pressure starts falling about 2 hours after a dose; the label says the effect is largely present within 2 weeks and maximal after about 4 weeks
Watch out for
Boxed warning: it can harm or kill a developing baby, so tell your prescriber at once if you become pregnant. It can raise blood potassium, especially with kidney disease, heart failure, potassium supplements, potassium salt substitutes or potassium-sparing diuretics, and can worsen kidney function in people whose kidneys depend on angiotensin II. Do not combine it with aliskiren if you have diabetes
What is it
Valsartan is a prescription angiotensin II receptor blocker (ARB) used to lower high blood pressure in adults and children 1 year and older, to reduce hospital stays for heart failure, and to lower the risk of dying from heart causes in people whose heart is weakened after a heart attack. It is sold as Diovan and generic valsartan tablets, and as Prexxartan oral solution, whose label covers high blood pressure in adults and in children 6 years and older (not younger children) and says it is not therapeutically equivalent to Diovan tablets; it is also one of the two ingredients in sacubitril/valsartan (Entresto) and in several combination blood pressure pills. It carries a boxed warning: drugs that act on the renin-angiotensin system can injure and kill a developing baby, so it is stopped as soon as pregnancy is found. Because it can raise blood potassium, potassium supplements and potassium salt substitutes are the key supplement concern.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
blood pressure Good Evidence | About 8/5 mmHg lower than placebo at trough for the ARB class | Adults with high blood pressure, including those who had a cough on an ACE inhibitor | Largely present within 2 weeks, maximal after about 4 weeks |
hospital stays for heart failure Good Evidence | About 13 percent lower combined morbidity and mortality; heart failure hospital stays 13.8 versus 18.2 percent | Adults with heart failure with reduced ejection fraction who cannot take an ACE inhibitor | Assessed over about 2 years |
survival in chronic heart failure Good Evidence | No difference in deaths | Not applicable | Assessed over about 2 years |
survival after a heart attack with heart failure or a weakened heart Good Evidence | Same death rate as captopril (hazard ratio 1.00); no gain from combining them | Adults after a heart attack with heart failure or a weakened heart, especially those who cannot take an ACE inhibitor | Assessed over a median of about 2 years |
blood pressure
- Effect
- About 8/5 mmHg lower than placebo at trough for the ARB class
- Best fit
- Adults with high blood pressure, including those who had a cough on an ACE inhibitor
- Time
- Largely present within 2 weeks, maximal after about 4 weeks
hospital stays for heart failure
- Effect
- About 13 percent lower combined morbidity and mortality; heart failure hospital stays 13.8 versus 18.2 percent
- Best fit
- Adults with heart failure with reduced ejection fraction who cannot take an ACE inhibitor
- Time
- Assessed over about 2 years
survival in chronic heart failure
- Effect
- No difference in deaths
- Best fit
- Not applicable
- Time
- Assessed over about 2 years
survival after a heart attack with heart failure or a weakened heart
- Effect
- Same death rate as captopril (hazard ratio 1.00); no gain from combining them
- Best fit
- Adults after a heart attack with heart failure or a weakened heart, especially those who cannot take an ACE inhibitor
- Time
- Assessed over a median of about 2 years
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
blood pressure
Biomarker supportA Cochrane review of 46 short randomized trials (3 to 12 weeks, 13,451 people with a starting blood pressure of 156/101 mmHg) found no meaningful difference between ARBs, including valsartan. Because of publication bias, the reviewers took the largest trials as the best estimate: about 8 mmHg lower systolic and 5 mmHg lower diastolic pressure at trough than placebo at the maximum recommended dose, similar to ACE inhibitors, with 60 to 70 percent of that effect at usual starting doses. The Diovan label reports placebo-corrected drops of about 6 to 9/3 to 5 mmHg at 80 to 160 mg and 9/6 mmHg at 320 mg. Blood pressure is a marker; the label notes there are no trials showing Diovan itself reduces heart events in high blood pressure.
Bottom line: Valsartan lowers blood pressure modestly, about as much as other ARBs and ACE inhibitors.
hospital stays for heart failure
Disease adjunctVal-HeFT randomized 5,010 people with heart failure (NYHA class II to IV, ejection fraction below 40 percent) already on standard treatment to valsartan (target 160 mg twice daily) or placebo for about 2 years. The combined endpoint of death, cardiac arrest with resuscitation, heart failure hospital stay or need for intravenous heart drugs was 13.2 percent lower on valsartan (relative risk 0.87), mainly from fewer heart failure hospital stays (13.8 versus 18.2 percent). The label says this benefit was driven largely by the 7 percent of patients not taking an ACE inhibitor, with little evidence of added benefit on top of an adequate ACE inhibitor dose. In a post hoc analysis, people taking valsartan with both an ACE inhibitor and a beta-blocker did worse, which raised a safety concern about that triple combination.
Bottom line: In one large trial, valsartan reduced heart failure hospital stays, mostly in people not on an ACE inhibitor.
Evidence is mixed
The overall combined endpoint favored valsartan, but a post hoc subgroup analysis suggested harm in people also taking both an ACE inhibitor and a beta-blocker, and the label attributes most of the benefit to the minority not taking an ACE inhibitor.
survival in chronic heart failure
No benefit foundIn the same Val-HeFT trial of 5,010 people with heart failure, deaths from any cause, one of the two primary endpoints, were similar on valsartan and placebo over about 2 years. The label reports 495 deaths (19.7 percent) on valsartan versus 484 (19.4 percent) on placebo (hazard ratio 1.02, 95 percent confidence interval 0.90 to 1.15). Valsartan is approved in heart failure to reduce hospital stays, not to prolong survival.
Bottom line: Valsartan did not lower deaths in chronic heart failure.
survival after a heart attack with heart failure or a weakened heart
Disease adjunctVALIANT randomized 14,703 people 0.5 to 10 days after a heart attack complicated by heart failure, a weakened left ventricle, or both, to valsartan, captopril (an ACE inhibitor proven in this setting), or both. Over a median of 24.7 months, deaths were 979 on valsartan, 958 on captopril and 941 on the combination (hazard ratio 1.00 for valsartan versus captopril), meeting the trial's test for being no worse than captopril. Combining the two gave more drug-related side effects without better survival. Low blood pressure and kidney problems were more common with valsartan alone; cough, rash and taste changes with captopril.
Bottom line: After a heart attack with a weakened heart, valsartan was as effective as captopril; using both added side effects, not survival.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose. Keep up with potassium and kidney blood tests, avoid potassium supplements and salt substitutes unless your prescriber approves them, and tell your doctor at once about a pregnancy.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning, fetal toxicity: drugs that act on the renin-angiotensin system can injure and kill a developing baby, mainly through reduced kidney function in the second and third trimesters. The label says to stop valsartan as soon as pregnancy is detected
High blood potassium (hyperkalemia), more likely with kidney impairment, heart failure, potassium supplements, potassium salt substitutes, potassium-sparing diuretics or other drugs that raise potassium
Worsening kidney function, including acute kidney failure, in people whose kidneys depend on the renin-angiotensin system (narrowed kidney arteries, chronic kidney disease, severe heart failure or dehydration)
Low blood pressure when starting treatment in people who are low on fluid or salt, for example on high-dose diuretics
Angioedema (swelling of the face, lips, throat) has been reported after marketing, some in people who had it before with other drugs such as ACE inhibitors; the label says valsartan should not be given again to anyone who has had angioedema on it
Who should avoid it
- Pregnant women: the boxed warning says to stop it as soon as pregnancy is detected
- People with diabetes who take aliskiren: contraindicated; the label also says to avoid aliskiren with valsartan when kidney function is reduced (GFR below 60 mL/min)
- People with known hypersensitivity to any component: contraindicated
- Children under 1 year: the label says use is not recommended
Pregnancy & breastfeeding
Pregnancy (boxed warning): drugs that act on the renin-angiotensin system, used in the second and third trimesters, reduce the baby's kidney function and raise the risk of injury and death in the baby before and after birth, including low amniotic fluid, underdeveloped lungs, skull and bone defects, kidney failure and low blood pressure. The label says to consider another treatment and stop valsartan as soon as pregnancy is detected. If you could become pregnant, discuss contraception and alternatives with your doctor, and tell your prescriber right away if you think you are pregnant. Breastfeeding: it is not known whether valsartan passes into human milk; it does in rats, and because of the potential for serious harm to a breastfed infant, the label advises against breastfeeding during treatment.
Interactions
The label says dual blockade of the renin-angiotensin system raises the risk of low blood pressure, high potassium and kidney failure compared with one drug, and most people gain no extra benefit. Aliskiren with valsartan is contraindicated in diabetes and should be avoided with reduced kidney function; in the VALIANT trial, combining valsartan with captopril after a heart attack added side effects without better survival. Your prescriber decides whether any such combination is needed and how to monitor it.
Blocking angiotensin II can make the kidneys hold on to potassium. The Diovan label says potassium supplements, salt substitutes containing potassium, potassium-sparing diuretics (such as spironolactone) and other drugs that raise potassium can increase blood potassium and, in heart failure, creatinine, and advises potassium monitoring if they are used together. Check labels for potassium chloride (common in "lite" or low-sodium salts) and use these products only if your prescriber has approved them and is checking your blood tests.
The label reports rises in lithium levels and lithium toxicity when lithium was taken with ARBs, and calls for monitoring lithium levels during combined use. Make sure the prescriber who manages your lithium knows you take valsartan.
In a 4-week randomized crossover trial in 52 people with high blood pressure, celery seed extract capsules (1.34 g a day) lowered 24-hour systolic pressure from 141.2 to 130.0 mmHg, with no change on placebo; celery juice itself has not been tested. Regular use could add to valsartan's effect and push readings lower than intended. Check your home blood pressure, watch for dizziness on standing, and review it with your doctor or pharmacist.
In older adults, people who are dehydrated or on diuretics, and people with reduced kidney function, NSAIDs plus valsartan can worsen kidney function, sometimes to acute kidney failure, usually reversibly; NSAIDs can also blunt valsartan's blood pressure effect. The label advises periodic kidney checks, so ask your doctor or pharmacist before using NSAIDs regularly.
A 2025 meta-analysis of randomized trials, rated moderate certainty by its authors, found spirulina lowered systolic blood pressure by about 4.4 mmHg and diastolic by about 2.8 mmHg, more clearly in people with high blood pressure. Combined with valsartan the effects may add a little; no study has tested the pair. Watch your home readings when you start it, and if you have kidney disease or take other potassium-raising medicines, ask your doctor or pharmacist before using it.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (2)
+ potassium
highValsartan blocks the effects of angiotensin II, including its signal for aldosterone release. In people with high blood pressure the Diovan label reports only minimal falls in aldosterone and very little effect on potassium, but some people with heart failure develop higher potassium, more often when kidney function is reduced. The label lists potassium supplements, salt substitutes containing potassium, potassium-sparing diuretics and other potassium-raising drugs as agents that may increase serum potassium, and advises monitoring potassium if they are used together.
+ spirulina
lowSpirulina lowered blood pressure modestly in randomized trials: a 2025 meta-analysis found drops of about 4.4 mmHg systolic and 2.8 mmHg diastolic, more clearly in people with high blood pressure. Taken with valsartan, the blood-pressure effects may add a little. No study has tested spirulina with valsartan or measured its effect on potassium in people taking valsartan. The Diovan label lists potassium supplements and other potassium-raising products as agents that may increase serum potassium, which matters most with kidney impairment or heart failure.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take potassium supplements or use salt substitutes with valsartan?⌄
Only if your prescriber has approved it and is checking your blood potassium. The label says potassium supplements and salt substitutes containing potassium can raise blood potassium with valsartan, and rises are more likely with kidney problems or heart failure. Many "lite" and low-sodium salts are potassium chloride, so read the ingredient list and ask your pharmacist.
Do I need to avoid bananas and other high-potassium foods on valsartan?⌄
The Diovan label does not restrict foods; its potassium warnings are about supplements, potassium salt substitutes and potassium-raising drugs. The risk of high potassium rises with kidney disease and heart failure, so some people are given a diet plan. Follow the diet and blood-test plan your prescriber gives you, and ask before making a big change in your diet.
Can I take spirulina or celery seed with valsartan?⌄
Both may lower blood pressure a little on their own: spirulina by about 4/3 mmHg in a meta-analysis of trials, and celery seed extract in one small trial. Neither has been tested with valsartan. Watch your home readings for lows or dizziness on standing, and check with your doctor or pharmacist first if you have kidney disease.
Is it safe to take ibuprofen or naproxen with valsartan?⌄
Occasional use may be fine for many people, but the label warns that NSAIDs with valsartan can worsen kidney function, especially in older adults, people who are dehydrated or on diuretics, and people with kidney problems, and can blunt the blood pressure effect. Ask your doctor or pharmacist before using them regularly.
What if I become pregnant while taking valsartan?⌄
Tell your prescriber right away. Valsartan carries a boxed warning because drugs of this type can injure and kill a developing baby, mainly in the second and third trimesters, and the label says to stop it as soon as pregnancy is detected and consider another treatment. If you could become pregnant, talk with your doctor about contraception and alternatives ahead of time.
Will valsartan give me a cough like lisinopril did?⌄
It is much less likely. In the label's comparisons, dry cough occurred in 2.6 percent of people on valsartan versus 7.9 percent on an ACE inhibitor, and in people who had coughed on an ACE inhibitor before, cough recurred in 20 percent on valsartan versus 69 percent on lisinopril. Tell your prescriber if a cough develops.
References by claim
blood pressure
Heran et al., 2008 · PMC (2008) link
hospital stays for heart failure
Cohn et al., 2001 · PubMed (2001) link
survival after a heart attack with heart failure or a weakened heart
Pfeffer et al., 2003 · PubMed (2003) link
Safety
Interaction: Celery juice and celery seed extract
Shayani Rad et al., 2022 · PubMed (2022) link
Interaction: Spirulina
Shiri et al., 2025 · PubMed (2025) link
Track Valsartan with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
